Alembic Pharma shares zoom 5% on USFDA approval for generic drug

The stock ended 4.09 higher per cent at Rs 842.70 against the previous close of Rs 809.60. 

Related Keywords

,Alembic Pharmaceuticals Limited ,Yale University ,Us Food Drug Administration ,Mayne Pharma International Pty ,Riglmmune Inc ,Drug Administration ,Abbreviated New Drug Application ,Doxycycline Hyclate Delayed Release Tablets ,Doryx Tablets ,Mayne Pharma International ,Doxycycline Hyclate Delayedrelease Tablets ,Mildly Bearish ,Bollinger Band ,Alembic Pharma ,Alembic Pharma Shares ,Lembic Pharma Stock ,Lembic Pharma Usfda ,Usfda ,